Vaccination of healthcare workers: A review

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 11, 2015, Pages 2522-2537

  Haviari, Skerdi ^a   Bénet, Thomas ^a,b,c   Saadatian Elahi, Mitra ^a   André, Philippe ^a   Loulergue, Pierre ^c,d   Vanhems, Philippe ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Coverage; Healthcare worker; Hepatitis; Influenza; Measles; Mumps; Nosocomial; Pertussis; Vaccination; Varicella

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; VACCINE;

DISEASE TRANSMISSION; ECONOMIC ASPECT; GUILLAIN BARRE SYNDROME; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEPATITIS B; HUMAN; INCIDENCE; INFLUENZA; MEASLES; MUMPS; NONHUMAN; PERTUSSIS; REVIEW; RUBELLA; VACCINATION; VARICELLA ZOSTER VIRUS; CROSS INFECTION; IMMUNOLOGY; PREVENTION AND CONTROL; UTILIZATION;

CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; HEALTH PERSONNEL; HUMANS; VACCINATION; VACCINES;

EID: 84976253969     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1082014     Document Type: Review

References (238)

1. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza — United States, 1976-2007. MMWR Morb Mortal Wkly Rep (2010); 59:1057-62 PMID:20798667
2. Vanhems P, Voirin N, Bénet T, Roche S, Escuret V, Régis C, Giard M, Lina B, Comte B, Coppéré B, et al. Detection of hospital outbreaks of influenza-like illness based on excess of incidence rates compared to the community. Am J Infect Control (2014); 42:1325-7 PMID:25444307; http://dx.doi.org/10.1016/j.ajic.2014.08.011
3. Voirin N, Barret B, Metzger MH, Vanhems P. Hospital-acquired influenza: a synthesis using the Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) statement. J Hosp Infect (2009); 71:1-14 PMID:18952319; http://dx.doi.org/10.1016/j.jhin.2008.08.013
4. Vanhems P, Voirin N, Roche S, Escuret V, Regis C, Gorain C, Pires-Cronenberger S, Giard M, Lina B, Najioullah F, et al. Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004-2005, 2005-2006, and 2006-2007: a prospective study. Arch Intern Med (2011); 171:151-7 PMID:21263105; http://dx.doi.org/10.1001/archinternmed.2010.500
5. Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, Karron RA, Walter EB; Centers for Disease Control and Prevention, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep (2014); 63:691-7 PMID:25121712
6. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol (2008); 167:775-85 PMID:18230677; http://dx.doi.org/10.1093/aje/kwm375
7. Joseph C, Togawa Y, Shindo N. Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses (2013); 7 Suppl 2:105-13 PMID:24034494; http://dx.doi.org/10.1111/irv.12089
8. Suess T, Remschmidt C, Schink SB, Schweiger B, Heider A, Milde J, Nitsche A, Schroeder K, Doellinger J, Braun C, et al. Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011. PLoS One (2012); 7(12):e51653 PMID:23240050; http://dx.doi.org/10.1371/journal.pone.0051653
9. Loeb M, Singh PK, Fox J, Russell ML, Pabbaraju K, Zarra D, Wong S, Neupane B, Singh P, Webby R, et al. Longitudinal study of influenza molecular viral shedding in Hutterite communities. J Infect Dis (2012); 206:1078-84 PMID:22837493; http://dx.doi.org/10.1093/infdis/jis450
10. Lau LL, Cowling BJ, Fang VJ, Chan KH, Lau EH, Lipsitch M, Cheng CK, Houck PM, Uyeki TM, Peiris JS, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis (2010); 201:1509-16 PMID:20377412; http://dx.doi.org/10.1086/652241
11. Eibach D, Casalegno JS, Bouscambert M, Bénet T, Regis C, Comte B, Kim BA, Vanhems P, Lina B. Routes of transmission during a nosocomial influenza A(H3N2) outbreak among geriatric patients and healthcare workers. J Hosp Infect (2014); 86:188-93 PMID:24468292; http://dx.doi.org/10.1016/j.jhin.2013.11.009
12. Francis JN, Bunce CJ, Horlock C, Watson JM, Warrington SJ, Georges B, Brown CB. A novel peptidebased pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety. Vaccine (2015); 33:396-402 PMID:24928790; http://dx.doi.org/10.1016/j.vaccine.2014.06.006
13. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2012); 12:36-44 PMID:22032844; http://dx.doi.org/10.1016/S1473-3099(11)70295-X
14. Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine (2011); 29:9159-70 PMID:21840359; http://dx.doi.org/10.1016/j.vaccine.2011.08.008
15. Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, et al., US Flu-VE Network. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis (2012); 55:951-9 PMID:22843783; http://dx.doi.org/10.1093/cid/cis574
16. Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2014); 58:319-27 PMID:24235265; http://dx.doi.org/10.1093/cid/cit736
17. McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk MP, Raviotta JM, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis (2015); 211(10):1529-40; http://dx.doi.org/10.1093/infdis/jiu647
18. Flannery B, Thaker SN, Clippard J, Monto AS, Ohmit SE, Zimmerman RK, Nowalk MP, Gaglani M, Jackson ML, Jackson LA, et al., Centers for Disease Control and Prevention (CDC). Interim estimates of 2013-14 seasonal influenza vaccine effectiveness-United States, February 2014. MMWR Morb Mortal Wkly Rep (2014); 63:137-42 PMID:24553196
19. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, et al. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep (2015); 64:10-5 PMID:25590680
20. Jefferson T. et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev (2014); 3:CD001269 PMID:24623315
21. Wilde JA, McMillan JA, Serwint J, Butta J, O’Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA (1999); 281:908-13 PMID:10078487; http://dx.doi.org/10.1001/jama.281.10.908
22. Saxén H, Virtanen M. Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatr Infect Dis J (1999); 18:779-83; http://dx.doi.org/10.1097/00006454-199909000-00007
23. Safranek TJ, Lawrence DN, Kurland LT, Culver DH, Wiederholt WC, Hayner NS, Osterholm MT, O’Brien P, Hughes JM. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. Am J Epidemiol (1991); 133:940-51 PMID:1851395
24. Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, Stukel TA, Crowcroft NS, McGeer AJ, Zinman L, et al. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis (2013); 13:769-76 PMID:23810252; http://dx.doi.org/10.1016/S1473-3099(13)70104-X
25. Tam CC, O’Brien SJ, Petersen I, Islam A, Hayward A, Rodrigues LC. Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS ONE (2007); 2:e344 PMID:17406668; http://dx.doi.org/10.1371/journal.pone.0000344
26. Miller E, Andrews N, Stellitano L, Stowe J, Winstone AM, Shneerson J, Verity C. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ (2013); 346:f794 PMID:23444425; http://dx.doi.org/10.1136/bmj.f794
27. Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen SL, Hublin C, Julkunen I, Olsén P, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE (2012); 7:e33536 PMID:22470453; http://dx.doi.org/10.1371/journal.pone.0033536
28. Han F, Lin L, Warby SC, Faraco J, Li J, Dong SX, An P, Zhao L, Wang LH, Li QY, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol (2011); 70:410-7 PMID:21866560; http://dx.doi.org/10.1002/ana.22587
29. Duffy J, Weintraub E, Vellozzi C, DeStefano F, Vaccine Safety Datalink. Narcolepsy and influenza A (H1N1) pandemic 2009 vaccination in the United States. Neurology (2014); 83:1823-30 PMID:25320099; http://dx.doi.org/10.1212/WNL.0000000000000987
30. Tsai T, Giudice GD, Crucitti A, Weil J, Narasimhan V. Is the adjuvant solely to blame? BMJ (2013); 346: f2375 PMID:23596217; http://dx.doi.org/10.1136/bmj.f2375
31. Demicheli V. et al. Vaccines for preventing influenza in healthy adults. Cochrane DatabaseSyst Rev (2014); 3:CD001269
32. Garbe E, Andersohn F, Bronder E, Salama A, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, et al. Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol (2011); 68:821-32 PMID:22187020; http://dx.doi.org/10.1007/s00228-011-1184-3
33. Grimaldi-Bensouda L, Michel M, Aubrun E, Leighton P, Viallard JF, Adoue D, Magy-Bertrand N, Tisserand G, Khellaf M, Durand JM, et al. A casecontrol study to assess the risk of immune thrombocytopenia associated with vaccines. Blood (2012); 120:4938-44 PMID:23100310; http://dx.doi.org/10.1182/blood-2012-05-431098
34. Shizuma T. Immune thrombocytopenia following influenza virus infection and influenza vaccine administration. Virology & Mycology (2014); S2:003
35. Scheifele DW, Duval B, Russell ML, Warrington R, DeSerres G, Skowronski DM, Dionne M, Kellner J, Davies D, MacDonald J. Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults. Clin Infect Dis (2003); 36:850-857 PMID:12652385; http://dx.doi.org/10.1086/368189
36. Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ (2011); 343:d5956 PMID:21994316; http://dx.doi.org/10.1136/bmj.d5956
37. Baxter R, Toback SL, Sifakis F, Hansen J, Bartlett J, Aukes L, Lewis N, Wu X, Ambrose CS. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age. Vaccine (2012); 30:3053-60 PMID:22425787; http://dx.doi.org/10.1016/j.vaccine.2012.02.080
38. Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med (2004); 350:896-903 PMID:14985487; http://dx.doi.org/10.1056/NEJMoa030595
39. Kanerva M, Nissinen J, Moilanen K, Mäki M, Lahdenne P, Pitkäranta A. Microbiologic findings in acute facial palsy in children. Otol Neurotol (2013); 34, e82-e87 PMID:23657208; http://dx.doi.org/10.1097/MAO.0b013e318289844c
40. Ray P, Black S, Shinefield H, Dillon A, Carpenter D, Lewis E, Ross P, Chen RT, Klein NP, Baxter R; Vaccine Safety Datalink Team. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age. Vaccine (2011); 29:6592-7 PMID:21763385; http://dx.doi.org/10.1016/j.vaccine.2011.06.112
41. Institute of Medicine. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press (2012) at
42. Potter J, Stott DJ, Roberts MA, Elder AG, O’Donnell B, Knight PV, Carman WF. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis (1997); 175:1-6 PMID:8985189; http://dx.doi.org/10.1093/infdis/175.1.1
43. Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, Murad S, Watson JM. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ (2006); 333:1241 PMID:17142257; http://dx.doi.org/10.1136/bmj.39010.581354.55
44. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, Stott DJ. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet (2000); 355:93-7 PMID:10675165; http://dx.doi.org/10.1016/S0140-6736(99)05190-9
45. Lemaitre M, Meret T, Rothan-Tondeur M, Belmin J, Lejonc JL, Luquel L, Piette F, Salom M, Verny M, Vetel JM. Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc (2009); 57:1580-6 PMID:19682118; http://dx.doi.org/10.1111/j.1532-5415.2009.02402.x
46. Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L. Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis (2014); 58:50-7 PMID:24046301; http://dx.doi.org/10.1093/cid/cit580
47. Bénet T, Régis C, Voirin N, Robert O, Lina B, Cronenberger S, Comte B, Coppéré B, Vanhems P. Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients. BMC Infect Dis (2012); 12:30; http://dx.doi.org/10.1186/1471-2334-12-30
48. Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol (2004); 25:923-8 PMID:15566025; http://dx.doi.org/10.1086/502321
49. Riphagen-Dalhuisen J, Burgerhof JG, Frijstein G, van derGeest-Blankert AD, Danhof-Pont MB, de Jager HJ, Bos AA, Smeets EE, de Vries MJ, Gallee PM, et al. Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands: 2009 to 2011. Euro Surveill (2013); 18:20512 PMID:23827527
50. Maltezou HC, Poland GA. Vaccination policies for healthcare workers in Europe. Vaccine (2014); 32:4876-80 PMID:24161573; http://dx.doi.org/10.1016/j.vaccine.2013.10.046
51. Australia Communicable Diseases Network and Australian Government Department of Health and Ageing. Influenza Infection: CDNA National Guidelines for Public Health Unit. at
52. Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep (2013); 62:1-43 PMID:AMBIGUOUS
53. Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec (2012); 87:461-76 PMID:23210147
54. Talbot TR, Babcock H, Caplan AL, Cotton D, Maragakis LL, Poland GA, Septimus EJ, Tapper ML, Weber DJ. Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol (2010); 31:987-95 PMID:20807037; http://dx.doi.org/10.1086/656558
55. Office of Disease Prevention and Health Promotion. Immunization and Infectious Diseases | Healthy People 2020. IID-12.13 Increase the percentage of health care personnel who are vaccinated annually against seasonal influenza at
56. Council of the European Union. Council recommendation of 22 December 2009 on seasonal influenza vaccination. Official Journal of the European Union (2009); 71-2
57. Sawyer MH, Peddecord KM, Wang W, Deguire M, Miskewitch-Dzulynsky M, Vuong DD. A public health initiative to increase annual influenza immunization among hospital health care personnel: the San Diego Hospital Influenza Immunization Partnership. Am J Infect Control (2012); 40:595-600 PMID:22264558; http://dx.doi.org/10.1016/j.ajic.2011.09.007
58. Miller BL, Ahmed F, Lindley MC, Wortley PM. Institutional requirements for influenza vaccination of healthcare personnel: results from a nationally representative survey of acute care hospitals-United States, 2011. Clin Infect Dis (2011); 53:1051-9 PMID:22045954; http://dx.doi.org/10.1093/cid/cir633
59. Riphagen-Dalhuisen J, Gefenaite G, Hak E. Predictors of seasonal influenza vaccination among healthcare workers in hospitals: a descriptive meta-analysis. Occup Environ Med (2012); 69:230-5 PMID:22172951; http://dx.doi.org/10.1136/oemed-2011-100134
60. Castilla J, Martínez-Baz I, Godoy P, Toledo D, Astray J, García S, Mayoral JM, Martín V, González-Candelas F, Guevara M, et al., CIBERESP Working Group for the Survey on Influenza Vaccination in Primary Healthcare Professionals. Trends in influenza vaccine coverage among primary healthcare workers in Spain:2008-2011. Prev Med (2013); 57:206-11 PMID:23732251; http://dx.doi.org/10.1016/j.ypmed.2013.05.021
61. Guthmann JP, Fonteneau L, Ciotti C, Bouvet E, Pellissier G, Lévy-Bruhl D, Abiteboul D. Vaccination coverage of health care personnel working in health care facilities in France: results of a national survey, 2009. Vaccine (2012); 30:4648-54 PMID:22579863; http://dx.doi.org/10.1016/j.vaccine.2012.04.098
62. Bonaccorsi G, Lorini C, Santomauro F, Guarducci S, Pellegrino E, Puggelli F, Balli M, Bonanni P. Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy. Hum Vaccin Immunother (2013); 9:2603-12 PMID:23954990; http://dx.doi.org/10.4161/hv.26036
63. Lu P, Santibanez TA, Williams WW, Zhang J, Ding H, Bryan L, O’Halloran A, Greby SM, Bridges CB, Graitcer SB, et al., Centers for Disease Control and Prevention (CDC). Surveillance of influenza vaccination coverage-United States, 2007-08 through 2011-12 influenza seasons. MMWR Surveill Summ (2013); 62:1-28 PMID:24157710
64. Yoon HJ, Lim J, Choi B, Kim J, Kim J, Kim C, Park JS, Hong SB, Seo J, Bae GR, et al. Vaccination rates and related factors among health care workers in South Korea, 2009. Am J Infect Control (2013); 41:753-4 PMID:23660111; http://dx.doi.org/10.1016/j.ajic.2013.01.034
65. Boccia A, Di Thiene D, De Giusti M, La Torre G. Seasonal and pandemic influenza: the role of communication and preventive strategies. J Prev Med Hyg (2011); 52:124-6 PMID:22010540
66. Song JY, Park CW, Jeong HW, Cheong HJ, Kim WJ, Kim SR. Effect of a hospital campaign for influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol (2006); 27:612-7 PMID:16755482; http://dx.doi.org/10.1086/504503
67. Garcell HG, Ramirez EC. Influenza immunization coverage for healthcare workers in a community hospital in Qatar (2011-2012 and 2012-2013 seasons). J Infect Public Health (2014); 7:70-2 PMID:24284023; http://dx.doi.org/10.1016/j.jiph.2013.06.007
68. Isaacs A, Chryssanthakis A, Abraham S. A cross-sectional audit of the uptake of the seasonal influenza vaccination by medical staff at a London hospital. Clin Med (2013); 13:633 PMID:24298125; http://dx.doi.org/10.7861/clinmedicine.13-6-633
69. Rebmann T, Wright KS, Anthony J, Knaup RC, Peters EB. Seasonal and H1N1 influenza vaccine compliance and intent to be vaccinated among emergency medical services personnel. Am J Infect Control (2012); 40:632-6 PMID:22464038; http://dx.doi.org/10.1016/j.ajic.2011.12.016
70. Chor JS, Pada SK, Stephenson I, Goggins WB, Tambyah PA, Clarke TW, Medina M, Lee N, Leung TF, Ngai KL, et al. Seasonal influenza vaccination predicts pandemic H1N1 vaccination uptake among healthcare workers in three countries. Vaccine (2011); 29:7364-9 PMID:21807048; http://dx.doi.org/10.1016/j.vaccine.2011.07.079
71. Gavazzi G, Filali-Zegzouti Y, Guyon AC, De Wazieres B, Lejeune B, Golmard JL, Belmin J, Piette F, Rothan-Tondeur M; French Geriatric Infection Risk Institute (ORIG)., French Geriatric Infection Risk Institute (ORIG). French healthcare workers in geriatric healthcare settings staunchly opposed to influenza vaccination: the VESTA study. Vaccine (2011); 29:1611-6 PMID:21211582; http://dx.doi.org/10.1016/j.vaccine.2010.12.067
72. Sočan M, Erčulj V, Lajovic J. Knowledge and attitudes on pandemic and seasonal influenza vaccination among Slovenian physicians and dentists. Eur J Public Health (2013); 23:92-7 PMID:22366387; http://dx.doi.org/10.1093/eurpub/cks006
73. Lehmann BA, Ruiter RA, Chapman G, Kok G. The intention to get vaccinated against influenza and actual vaccination uptake of Dutch healthcare personnel. Vaccine (2014); 32:6986-91 PMID:25454867; http://dx.doi.org/10.1016/j.vaccine.2014.10.034
74. Johansen LJ, Stenvig T, Wey H. The decision to receive influenza vaccination among nurses in North and South Dakota. Public Health Nurs (2012); 29:116-25 PMID:22372448; http://dx.doi.org/10.1111/j.1525-1446.2011.00966.x
75. Bali NK, Ashraf M, Ahmad F, Khan UH, Widdowson MA, Lal RB, Koul PA. Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar, India. Influenza Other Respir Viruses (2013); 7:540-5 PMID:22862774; http://dx.doi.org/10.1111/j.1750-2659.2012.00416.x
76. Friedl A, Aegerter C, Saner E, Meier D, Beer JH. An intensive 5-year-long influenza vaccination campaign is effective among doctors but not nurses. Infection (2012); 40:57-62 PMID:21956456; http://dx.doi.org/10.1007/s15010-011-0193-6
77. Ribner BS, Hall C, Steinberg JP, Bornstein WA, Beasley K, Duffell JM, De Gennaro M, Garner D. A Web based program to ensure compliance of medical staff providers with mandated health care facility requirements. Am J Infect Control (2011); 39:511-4 PMID:21496954; http://dx.doi.org/10.1016/j.ajic.2010.08.021
78. Cadena J, Prigmore T, Bowling J, Ayala BA, Kirkman L, Parekh A, Scepanski T, Patterson JE. Improving influenza vaccination of healthcare workers by means of quality improvement tools. Infect Control Hosp Epidemiol (2011); 32:616-8 PMID:21558776; http://dx.doi.org/10.1086/660198
79. Perlin JB, Septimus EJ, Cormier SB, Moody JA, Hickok JD, Bracken RM. Developing a program to increase seasonal influenza vaccination of healthcare workers: lessons from a system of community hospitals. J Healthc Qual (2013); 35:5-15; http://dx.doi.org/10.1111/jhq.12005
80. Esolen LM, Kilheeney KL, Merkle RE, Bothe A. An alternate approach to improving healthcare worker influenza vaccination rates. Infect Control Hosp Epidemiol (2011); 32:703-5 PMID:21666402; http://dx.doi.org/10.1086/660762
81. Modak RM, Parris SM, Dilisi JP, Premkumar A. Increasing influenza vaccination rates among hospital employees without a mandatory policy. Infect Control Hosp Epidemiol (2012); 33:1288-9 PMID:23143379; http://dx.doi.org/10.1086/667384
82. Quan K, Tehrani DM, Dickey L, Spiritus E, Hizon D, Heck K, Samuelson P, Kornhauser E, Zeitany R, Mancia S, et al. Voluntary to mandatory: evolution of strategies and attitudes toward influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol (2012); 33:63-70 PMID:22173524; http://dx.doi.org/10.1086/663210
83. Honda H, Sato Y, Yamazaki A, Padival S, Kumagai A, Babcock H. A successful strategy for increasing the influenza vaccination rate of healthcare workers without a mandatory policy outside of the United States: a multifaceted intervention in a Japanese tertiary care center. Infect Control Hosp Epidemiol (2013); 34:1194-200 PMID:24113604; http://dx.doi.org/10.1086/673452
84. Heinrich-Morrison K, McLellan S, McGinnes U, Carroll B, Watson K, Bass P, Worth LJ, Cheng AC. An effective strategy for influenza vaccination of healthcare workers in Australia: experience at a large health service without a mandatory policy. BMC Infect Dis (2015); 15:42 PMID:25656220; http://dx.doi.org/10.1186/s12879-015-0765-7
85. Lin CJ, Nowalk MP, Zimmerman RK. Estimated costs associated with improving influenza vaccination for health care personnel in a multihospital health system. Jt Comm J Qual Patient Saf (2012); 38:67-72 PMID:22372253
86. Daugherty EL, Speck KA, Rand CS, Perl TM. Perceptions and influence of a hospital influenza vaccination policy. Infect Control Hosp Epidemiol (2011); 32:449-55 PMID:21515975; http://dx.doi.org/10.1086/659406
87. Maurer J, Harris KM, Black CL, Euler GL. Support for seasonal influenza vaccination requirements among US healthcare personnel. Infect Control Hosp Epidemiol (2012); 33:213-21 PMID:22314055; http://dx.doi.org/10.1086/664056
88. Karanfil LV, Bahner J, Hovatter J, Thomas WL. Championing patient safety through mandatory influenza vaccination for all healthcare personnel and affiliated physicians. Infect Control Hosp Epidemiol (2011); 32:375-9 PMID:21460489; http://dx.doi.org/10.1086/659155
89. Huynh S, Poduska P, Mallozzi T, Culler F. Mandatory influenza vaccination of health care workers: a first-year success implementation by a community health care system. Am J Infect Control (2012); 40:771-3 PMID:22325484; http://dx.doi.org/10.1016/j.ajic.2011.10.011
90. Kidd F, Wones R, Momper A, Bechtle M, Lewis M. From 51% to 100%: mandatory seasonal influenza vaccination. Am J Infect Control (2012); 40:188-90 PMID:21764181; http://dx.doi.org/10.1016/j.ajic.2011.02.022
91. Floyd B. Mandatory influenza vaccination program proves successful in its first year. N C Med J (2013); 74:426 PMID:24165776
92. Rakita RM, Hagar BA, Crome P, Lammert JK. Mandatory influenza vaccination of healthcare workers: a 5-year study. Infect Control Hosp Epidemiol (2010); 31:881-8 PMID:20653445; http://dx.doi.org/10.1086/656210
93. Ksienski DS. Mandatory seasonal influenza vaccination or masking of British Columbia health care workers: year 1. Can J Public Health (2014); 105, e312-e316 PMID:25166135
94. Centers for Disease Control and Prevention. Recommended Immunization Schedule for Persons Aged 0 Through 18 Years, United States (2015) at
95. Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff SB, Tran TN, Amin MA, Seminack MM, Vagie KA, Dana A, et al. Measles, mumps, and rubella virus vaccine (M-M-RTMII): a review of 32 years of clinical and postmarketing experience. Vaccine (2012); 30:6918-26 PMID:22959986; http://dx.doi.org/10.1016/j.vaccine.2012.08.057
96. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS., Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps:2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2013); 62:1-34 PMID:23760231
97. Perry RT et al. Global progress towards regional measles elimination, worldwide, 2000-2013. Wkly Epidemiol Rec (2014); 89:509-16 PMID:25401192
98. Anderson RM, May RM. Immunisation and herd immunity. The Lancet (1990); 335:641-5; http://dx.doi.org/10.1016/0140-6736(90)90420-A
99. Simone B, Carrillo-Santisteve P, Lopalco PL. Healthcare workers role in keeping MMR vaccination uptake high in Europe: a review of evidence. Euro Surveill (2012); 17:pii: 20206
100. Centers for Disease Control and Prevention (CDC). Increased transmission and outbreaks of measles-European Region, 2011. MMWR Morb Mortal Wkly Rep (2011); 60:1605-10 PMID:22129994
101. European Centre for Disease Prevention and Control. Measles surveillance data. at
102. Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: The US experience. JAMA Pediatr (2014) 168:148-55 PMID:24311021; http://dx.doi.org/10.1001/jamapediatrics.2013.4342
103. Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K; Centers for Disease Control and Prevention (CDC)., Centers for Disease Control and Prevention (CDC). Measles outbreak-California, December 2014-February 2015. MMWR Morb Mortal Wkly Rep (2015); 64:153-4 PMID:25695321
104. Centers for Disease Control and Prevention (CDC). Measles-United States, 2011. MMWR Morb Mortal Wkly Rep (2012); 61:253-7 PMID:22513526
105. McCarthy M. Measles cases exceed 100 in US outbreak. BMJ (2015); 350:h622 PMID:25646696; http://dx.doi.org/10.1136/bmj.h622
106. Hviid A, Rubin S, Mühlemann K. Mumps. The Lancet (2008); 371:932-44; http://dx.doi.org/10.1016/S0140-6736(08)60419-5
107. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med (2012); 367:1704-13 PMID:23113481; http://dx.doi.org/10.1056/NEJMoa1202865
108. Centers for Disease Control and Prevention (CDC). Mumps outbreak on a university campus-California, 2011. MMWR Morb Mortal Wkly Rep (2012); 61:986-9 PMID:23222373
109. Centers for Disease Control and Prevention (CDC). Update: Mumps outbreak-New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep (2010); 59:125-9 PMID:20150887
110. Maillet M, Bouvat E, Robert N, Baccard-Longére M, Morel-Baccard C, Morand P, Vabret A, Stahl JP. Mumps outbreak and laboratory diagnosis. J Clin Virol (2015); 62:14-9 PMID:25542464; http://dx.doi.org/10.1016/j.jcv.2014.11.004
111. Sane J, Gouma S, Koopmans M, deMelker H, Swaan C, vanBinnendijk R, Hahné S. Epidemic ofmumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis (2014); 20:643-8 PMID:24655811; http://dx.doi.org/10.3201/eid2004.131681
112. Gobet A, Mayet A, Journaux L, Dia A, Aigle L, Dubrous P, Michel R. Mumps among highly vaccinated people: investigation of an outbreak in a French military parachuting unit, 2013. J Infect (2014); 68:101-2 PMID:24035994; http://dx.doi.org/10.1016/j.jinf.2013.09.004
113. Strebel PM, Gacic-Dobo M, Reef S, Cochi SL. Global use of rubella vaccines, 1980-2009. J Infect Dis (2011); 204 Suppl 2:S579-84 PMID:21954250; http://dx.doi.org/10.1093/infdis/jir447
114. Zimmerman LA, Muscat M, Jankovic D, Goel A, Bang H, Khetsuriani N, Martin R. Status of rubella and congenital rubella syndrome surveillance, 2005-2009, the World Health Organization European Region. J Infect Dis (2011); 204 Suppl 1:S381-8 PMID:21666188; http://dx.doi.org/10.1093/infdis/jir104
115. WHO Epidemiological Brief 26: Measles, rubella and polio update from WHO/Europe. at
116. Mossong J, Muller CP. Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiol Infect (2000); 124:273-8 PMID:10813153; http://dx.doi.org/10.1017/S0950268899003672
117. Botelho-Nevers E, Cassir N, Minodier P, Laporte R, Gautret P, Badiaga S, Thiberville DJ, Ninove L, Charrel R, Brouqui P. Measles among healthcare workers: a potential for nosocomial outbreaks. Euro Surveill (2011); 16:pii: 19764 PMID:21284921
118. Muscat M. Who gets measles in Europe? J Infect Dis (2011); 204 Suppl 1:S353-S365 PMID:21666185; http://dx.doi.org/10.1093/infdis/jir067
119. Choi WS, Sniadack DH, Jee Y, Go UY, So JS, Cho H, Bae GR, Lee DH, Kim K, Yoon HS, et al. Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission. J Infect Dis (2011); 204 Suppl 1:S483-S490 PMID:21666204; http://dx.doi.org/10.1093/infdis/jir087
120. Chen SY, Anderson S, Kutty PK, Lugo F, McDonald M, Rota PA, Ortega-Sanchez IR, Komatsu K, Armstrong GL, Sunenshine R, et al. Health care-associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis (2011); 203:1517-25 PMID:21531693; http://dx.doi.org/10.1093/infdis/jir115
121. Tajima K, Nishimura H, Hongo S, Hazawa M, Saotome-Nakamura AI, Tomiyama K, Obara C, Kato T. Estimation of secondary measles transmission from a healthcare worker in a hospital setting. Int J Infect Dis (2014); 24:11-3 PMID:24780918; http://dx.doi.org/10.1016/j.ijid.2014.03.1377
122. Baxi R, Mytton OT, Abid M, Maduma-Butshe A, Iyer S, Ephraim A, Brown KE, O’Moore é. Outbreak report: nosocomial transmission of measles through an unvaccinated healthcare worker-implications for public health. J Public Health (Oxf) (2014); 36:375-81 PMID:24099734; http://dx.doi.org/10.1093/pubmed/fdt096
123. Bonebrake AL, Silkaitis C, Monga G, Galat A, Anderson J, Trad JT, Hedley K, Burgess N, Zembower TR. Effects of mumps outbreak in hospital, Chicago, Illinois, USA, 2006. Emerg Infect Dis (2010); 16:426-32 PMID:20202417; http://dx.doi.org/10.3201/eid1603.090198
124. Gilroy SA, Domachowske JB, Johnson L, Martin D, Gross S, Bode M, Costello K, Sikora R, Richey D, Watkins J, et al. Mumps exposure of a health care provider working in a neonatal intensive care unit leads to a hospital-wide effort that prevented an outbreak. Am J Infect Control (2011); 39:697-700 PMID:21641085; http://dx.doi.org/10.1016/j.ajic.2010.12.011
125. European Centre for Disease Prevention and Control. Review of outbreaks and barriers to MMR vaccination coverage among hard-to-reach populations in Europe: Venice II Consortium. (ECDC, 2013)
126. Plotkin SA, Orenstein W, Offit PA. Vaccines. Philadelphia: Saunders (2012)
127. Measles Vaccine-Part 4-Active Vaccines-Canadian Immunization Guide-Public Health Agency of Canada. at
128. The Australian Immunization Handbook (Immunise-4.9 Measles). at
129. Prabhakar P, Irons B, Figueroa JP, de Quadros C. Immunization of health care workers in the CARICOM countries. West Indian Med J (2000); 49:353-5 PMID:11211552
130. Maltezou HC, Wicker S, Borg M, Heininger U, Puro V, Theodoridou M, Poland GA. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine (2011); 29:9557-62 PMID:21964058; http://dx.doi.org/10.1016/j.vaccine.2011.09.076
131. O’Flanagan D, Cotter S, Mereckiene J. Analysis of determinants for low MMR vaccination coverage in Europe. at
132. Fiebelkorn AP, Seward JF, Orenstein WA. A global perspective of vaccination of healthcare personnel against measles: systematic review. Vaccine (2014); 32:4823-39 PMID:24280280; http://dx.doi.org/10.1016/j.vaccine.2013.11.005
133. Fortunato F, Tafuri S, Cozza V, Martinelli D, Prato R. Low vaccination coverage among Italian healthcare workers in 2013. Hum Vaccin Immunother (2015); 11:133-9 PMID:25483526; http://dx.doi.org/10.4161/hv.34415
134. Maltezou HC, Katerelos P, Poufta S, Pavli A, Maragos A, Theodoridou M. Attitudes toward mandatory occupational vaccinations and vaccination coverage against vaccine-preventable diseases of health care workers in primary health care centers. Am J Infect Control (2013); 41:66-70 PMID:22709989; http://dx.doi.org/10.1016/j.ajic.2012.01.028
135. Hees L, Afroukh N, Floret D.; Vaccination coverage among health care workers in the pediatric emergency and intensive care department of Edouard Herriot Hospital in 2007, against influenza, pertussis, varicella, and measles. Arch Pediatr (2009); 16:14-22 PMID:19095425; http://dx.doi.org/10.1016/j.arcped.2008.10.017
136. Campins M, Urbiztondo L, Costa J, Broner S, Esteve M, Bayas JM, Borras E, Dominguez A; Working Group for the Study of the Immune Status in Healthcare Workers of Catalonia., Serological survey of mumps immunity among health care workers in the Catalonia region of Spain. Am J Infect Control (2013); 41:378-80 PMID:23040604; http://dx.doi.org/10.1016/j.ajic.2012.04.327
137. Mohammad A, Trape M, Khan Y. Serological survey of mumps immunity among healthcare workers in Connecticut, December 2006-May 2007. Infect Control Hosp Epidemiol (2009); 30:202-3 PMID:19146465; http://dx.doi.org/10.1086/593966
138. Weber SH. et al. Hospital and clinical laboratory response to mumps exposures. Lab Med (2007); 38:285-8; http://dx.doi.org/10.1309/PG44B3AALG8VQM5F
139. Borrás E, Campins M, Esteve M, Urbiztondo L, Broner S, Bayas JM, Costa J, Domínguez A. Working Group for the Study of the Immune Status in Healthcare Workers. Are healthcare workers immune to rubella? Hum Vaccin Immunother (2014); 10:686-91; http://dx.doi.org/10.4161/hv.27498
140. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine (2012); 30:2212-9 PMID:22273662; http://dx.doi.org/10.1016/j.vaccine.2011.12.116
141. Duffell EF, vandeLaar MJ, Amato-Gauci AJ. Enhanced surveillance of hepatitis B in the EU:2006-2012. J Viral Hepat (2015); 22:581-9 PMID:25417854; http://dx.doi.org/10.1111/jvh.12364
142. Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, de Perio MA, Reilly M, Byrd K, Ward JW; Centers for Disease Control and Prevention (CDC). CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep (2013); 62:1-19 PMID:24352112
143. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, Mares A, Miller JK, Moyer LA. The changing epidemiology of hepatitis b in the United States. Need for alternative vaccination strategies. JAMA (1990); 263:1218-22 PMID:2304237; http://dx.doi.org/10.1001/jama.1990.03440090052025
144. Wise ME, Marquez P, Sharapov U, Hathaway S, Katz K, Tolan S, Beaton A, Drobeniuc J, Khudyakov Y, Hu DJ. Outbreak of acute hepatitis B virus infections associated with podiatric care at a psychiatric long-term care facility. Am J Infect Control (2012); 40:16-21 PMID:21835502; http://dx.doi.org/10.1016/j.ajic.2011.04.331
145. Kliner M, Dardamissis E, Abraham KA, Sen R, Lal P, Pandya B, Mutton KJ, Wong C. Identification, investigation and management of patient-topatient hepatitis B transmission within an inpatient renal ward in North West England. Clin Kidney J (2015); 8:102-6 PMID:25713718; http://dx.doi.org/10.1093/ckj/sfu130
146. Perz JF, Grytdal S, Beck S, Fireteanu AM, Poissant T, Rizzo E, Bornschlegel K, Thomas A, Balter S, Miller J, et al. Case-control study of hepatitis B and hepatitis C in older adults: do healthcare exposures contribute to burden of new infections? Hepatology (2013); 57:917-24 PMID:22383058; http://dx.doi.org/10.1002/hep.25688
147. Harpaz R, Von Seidlein L, Averhoff FM, Tormey MP, Sinha SD, Kotsopoulou K, Lambert SB, Robertson BH, Cherry JD, Shapiro CN. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med (1996); 334:549-54 PMID:8569821; http://dx.doi.org/10.1056/NEJM199602293340901
148. Farez MF, Correale J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol (2011); 258:1197-206 PMID:21431896; http://dx.doi.org/10.1007/s00415-011-5984-2
149. Pellissier G, Yazdanpanah Y, Adehossi E, Tosini W, Madougou B, Ibrahima K, Lolom I, Legac S, Rouveix E, Champenois K. Is universal HBV vaccination of healthcare workers a relevant strategy in developing endemic countries? The case of a university hospital in Niger. PLoS ONE (2012); 7:e44442 PMID:22970218; http://dx.doi.org/10.1371/journal.pone.0044442
150. Byrd KK, Lu P, Murphy TV. Hepatitis B vaccination coverage among health-care personnel in the United States. Public Health Rep (2013); 128:498-509 PMID:24179261
151. Loulergue P, Fonteneau L, Armengaud JB, Momcilovic S, Levy-Brühl D, Launay O, Guthmann JP; Studyvax survey group. Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey. Vaccine (2013); 31:2835-8 PMID:23623864; http://dx.doi.org/10.1016/j.vaccine.2013.04.004
152. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis (1999); 28:S107-S111 PMID:10447027; http://dx.doi.org/10.1086/515057
153. Gordon JE, Hood RI. Whooping cough and its epidemiological anomalies. Am J Med Sci (1951); 222:333-61 PMID:14877820; http://dx.doi.org/10.1097/00000441-195109000-00011
154. US Bureau of the Census. Historical Statistics of the United States. Colonial times to 1970, Bicentennial Edition. 1-58 Washington, DC (1975) at
155. Cherry JD. Epidemic pertussis in 2012 — the resurgence of a vaccine-preventable disease. N Engl J Med (2012); 367:785-7 PMID:22894554; http://dx.doi.org/10.1056/NEJMp1209051
156. European Centre for Disease Prevention and Control Annual epidemiological report 2014-Vaccine-preventable diseases. Stockholm: ECDC (2014); at http://www.ecdc.europa.eu/en/publications/Publications/AER-2014-VPD-FINAL.pdf
157. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediat Infect Dis J (2005); 24:761-5; http://dx.doi.org/10.1097/01.inf.0000177282.53500.77
158. WHO SAGE Pertussis Working Group. Background paper. SAGE April 2014. Available at http://www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf?ua=1;accessedFebruary2015
159. Plotkin SA. The pertussis problem. Clin Infect Dis (2014); 58:830-3 PMID:24363332; http://dx.doi.org/10.1093/cid/cit934
160. Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Vaccine (2012); 30:5179-90 PMID:22709953; http://dx.doi.org/10.1016/j.vaccine.2012.06.005
161. Heininger U. Vaccination of health care workers against pertussis: meeting the need for safety within hospitals. Vaccine (2014); 32:4840-3 PMID:24183977; http://dx.doi.org/10.1016/j.vaccine.2013.10.062
162. Maltezou HC, Ftika L, Theodoridou M. Nosocomial pertussis in neonatal units. J Hosp Infect (2013); 85:243-8 PMID:24156850; http://dx.doi.org/10.1016/j.jhin.2013.09.009
163. Rivero-Santana A, Cuéllar-Pompa L, Sánchez-Gómez LM, Perestelo-Pérez L, Serrano-Aguilar P. Effectiveness and cost-effectiveness of different immunization strategies against whooping cough to reduce child morbidity and mortality. Health Policy (2014); 115:82-91 PMID:24444703; http://dx.doi.org/10.1016/j.healthpol.2013.12.007
164. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol (2010); 17:1055-65 PMID:20463105; http://dx.doi.org/10.1128/CVI.00131-10
165. Greer AL, Fisman DN. Keeping vulnerable children safe from pertussis: preventing nosocomial pertussis transmission in the neonatal intensive care unit. Infect Control Hosp Epidemiol (2009); 30:1084-9 PMID:19785517; http://dx.doi.org/10.1086/644755
166. Greer AL, Fisman DN. Use of models to identify cost effective interventions: pertussis vaccination for pediatric health care workers. Pediatrics (2011); 128:e591-e599 PMID:21844056
167. Kuncio DE, Middleton M, Cooney MG, Ramos M, Coffin SE, Feemster KA. Health care worker exposures to pertussis: missed opportunities for prevention. Pediatrics (2014); 133:15-21 PMID:24344101; http://dx.doi.org/10.1542/peds.2013-0745
168. Urbiztondo L, Broner S, Costa J, Rocamora L, Bayas JM, Campins M, Esteve M, Borras E, Domínguez A, For The Study Of The Immune Status In Health Care TW. Seroprevalence study of B. pertussis infection in health care workers in Catalonia, Spain. Hum Vaccine Immunother (2015); 11:293-7; http://dx.doi.org/10.4161/hv.36167
169. Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol (1999); 20:120-3 PMID:10064216; http://dx.doi.org/10.1086/501593
170. Faruque MO, Senanayake S, Meyer AD, Dear KB. Emergency department staff and susceptibility to pertussis: a seroprevalence study. Emerg Med Australas (2008); 20:45-50 PMID:18062780; http://dx.doi.org/10.1111/j.1742-6723.2007.01044.x
171. Yih WK, Nordin JD, Kulldorff M, Lewis E, Lieu TA, Shi P, Weintraub ES. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine (2009); 27:4257-62 PMID:19486957; http://dx.doi.org/10.1016/j.vaccine.2009.05.036
172. Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, et al. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine (2014); 32:3019-24 PMID:24699471; http://dx.doi.org/10.1016/j.vaccine.2014.03.063
173. Weber DJ, Rutala WA. in Vaccines (Plotkin SA, Orenstein WA, Offit PA, Eds., Philadelphia: Saunders (2008) 1453-78)
174. Taddei C, Ceccherini V, Niccolai G, Porchia BR, Boccalini S, Levi M, Tiscione E, Santini MG, Baretti S, Bonanni P, et al. Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. Hum Vacc Immunother (2014); 10:2612-22; http://dx.doi.org/10.4161/21645515.2014.970879
175. Mir O, Adam J, Gaillard R, Gregory T, Veyrie N, Yordanov Y, Berveiller P, Chousterman B, Loulergue P. Vaccination coverage among medical residents in Paris, France. Clin Microbiol Infect (2012); 18:E137-E139 PMID:22404767; http://dx.doi.org/10.1111/j.1469-0691.2012.03788.x
176. Faure E, Cortot C, Gosset D, Cordonnier A, Deruelle P, Guery B. Vaccinal status of healthcare students in Lille. Méd Mal Infect (2013); 43:114-7; http://dx.doi.org/10.1016/j.medmal.2013.02.002
177. Duong M, Mahy S, Binois R, Buisson M, Piroth L, Chavanet P.; Vaccination coverage of healthcare professionals in an infectious diseases department. Méd Mal Infect (2011); 41:135-9; http://dx.doi.org/10.1016/j.medmal.2010.11.018
178. Vic P, Puech J.; Health care workers’ knowledge and vaccination coverage against pertussis in a French pediatric and maternity ward. Arch Pediatr (2011); 18:1339-40 PMID:22041593; http://dx.doi.org/10.1016/j.arcped.2011.09.029
179. Esolen LM, Kilheeney KL. A mandatory campaign to vaccinate health care workers against pertussis. Am J Infect Control (2013); 41:740-2 PMID:23394887; http://dx.doi.org/10.1016/j.ajic.2012.10.012
180. Weber DJ, Consoli SA, Sickbert-Bennett E, Rutala WA. Assessment of a mandatory tetanus, diphtheria, and pertussis vaccination requirement on vaccine uptake over time. Infect Control Hosp Epidemiol (2012); 33:81-3 PMID:22173527; http://dx.doi.org/10.1086/663337
181. Mayet A, Duron S, Meynard JB, Koeck JL, Deparis X, Migliani R. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012. Public Health (2015); 129:763-8 PMID:25890634; http://dx.doi.org/10.1016/j.puhe.2015.03.003
182. Beytout J, Launay O, Guiso N, Fiquet A, Baudin M, Richard P, Baptiste C, Soubeyrand B. Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial. Hum Vaccin (2009); 5:315-21 PMID:19011374; http://dx.doi.org/10.4161/hv.5.5.6911
183. Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine (2010); 28:8001-7 PMID:20875487
184. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep (2011); 60:13-5 PMID:21228763
185. Bar-On ES, Goldberg E, Hellmann S, Leibovici L. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenzae B (HIB). Cochrane Database Syst Rev (2012); 4:CD005530 PMID:22513932
186. CDC. Tetanus: vaccine recommendations. at
187. Maltezou HC, Lourida A, Katragkou A, Grivea IN, Katerelos P, Wicker S, Syrogiannopoulos GA, Roilides E, Theodoridou M. Attitudes regarding occupational vaccines and vaccination coverage against vaccine-preventable diseases among healthcare workers working in pediatric departments in Greece. Pediat Infect Dis J (2012); 31:623-5; http://dx.doi.org/10.1097/INF.0b013e31824ddc1e
188. Maltezou HC, Gargalianos P, Nikolaidis P, Katerelos P, Tedoma N, Maltezos E, Lazanas M. Attitudes towards mandatory vaccination and vaccination coverage against vaccine-preventable diseases among healthcare workers in tertiary-care hospitals. J Infect (2012); 64:319-24 PMID:22198739; http://dx.doi.org/10.1016/j.jinf.2011.12.004
189. Lu PJ, Euler GL. Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States. Am J Infect Control (2011); 39:488-94 PMID:21288599; http://dx.doi.org/10.1016/j.ajic.2010.10.009
190. Wiboonchutikul S, Manosuthi W, Sangsajja C, Thientong V, Likanonsakul S, Srisopha S, Termvises P, Rujitip J, Loiusirirotchanakul S, Puthavathana P. Baseline immunity to diphtheria and immunologic response after booster vaccination with reduced diphtheria and tetanus toxoid vaccine in Thai health care workers. Am J Infect Control (2014); 42:e81-e83 PMID:24751139; http://dx.doi.org/10.1016/j.ajic.2014.03.005
191. Esteve M, Domínguez A, Urbiztondo L, Borrás E, Costa J, Broner S, Campins M, Bayas JM; Working Group for the Study of the Immune Status in Healthcare Workers in Catalonia. Prevalence of susceptibility to tetanus and diphtheria in health care workers in Catalonia. Am J Infect Control (2012); 40:896-8 PMID:22386155; http://dx.doi.org/10.1016/j.ajic.2011.11.012
192. Urbiztondo L, Bayas JM, Broner S, Costa J, Esteve M, Campins M, Borrás E, Domínguez A; Working Group for the Study of the Immune Status in Healthcare Workers of Catalonia. Varicella-zoster virus immunity among health care workers in Catalonia. Vaccine (2014); 32:5945-8 PMID:25219564; http://dx.doi.org/10.1016/j.vaccine.2014.08.055
193. Heininger U, Seward JF. Varicella. The Lancet (2006); 368:1365-76; http://dx.doi.org/10.1016/S0140-6736(06)69561-5
194. Apisarnthanarak A, Kitphati R, Tawatsupha P, Thongphubeth K, Apisarnthanarak P, Mundy LM. Outbreak of Varicella-Zoster virus infection among Thai healthcare workers. Infect Control Hosp Epidemiol (2007); 28:430-4 PMID:17385149; http://dx.doi.org/10.1086/512639
195. Wurtz R, Check IJ. Breakthrough Varicella infection in a healthcare worker despite immunity after varicella vaccination. Infect Control Hosp Epidemiol (1999); 20:561-2;PMID:10466558; http://dx.doi.org/10.1086/501670
196. Fernández-Cano MI, Armadans L, Sulleiro E, Espuga M, Ferrer E, Martínez-Gomez X, Vaqué J, Campins M.; Susceptibility to measles and varicella in healthcare workers in a tertiary hospital in Catalonia. Enferm Infecc Microbiol Clin (2012); 30:184-8; http://dx.doi.org/10.1016/j.eimc.2011.10.002
197. Kurukulasooriya GM, Thevanesam V, Agampodi SB, Abeykoon AM, Amarasiri SP, Goonasekera KP. Susceptibility of new entrant university students in Sri Lanka to varicella zoster infection. Asia Pac J Public Health (2010); 22:219-24 PMID:19411280; http://dx.doi.org/10.1177/1010539509334625
198. Kellie SM, Makvandi M, Muller ML. Management and outcome of a varicella exposure in a neonatal intensive care unit: lessons for the vaccine era. Am J Infect Control (2011); 39:844-8 PMID:21600672; http://dx.doi.org/10.1016/j.ajic.2011.02.006
199. Vázquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, Shapiro ED. Effectiveness over time of varicella vaccine. JAMA (2004); 291:851-5; http://dx.doi.org/10.1001/jama.291.7.851
200. Goulleret N, Mauvisseau E, Essevaz-Roulet M, Quinlivan M, Breuer J. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). Vaccine (2010); 28:5878-82 PMID:20600487; http://dx.doi.org/10.1016/j.vaccine.2010.06.056
201. Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG. The safety profile of Varicella vaccine: a 10-year review. J Infect Dis (2008); 197:S165-S169 PMID:18419392; http://dx.doi.org/10.1086/522125
202. Ferenczi K, Berke A, Cichon D, Jurzyk R, Somach SC. Varicella-zoster virus vaccination-induced granulomatous dermatitis. J Am Acad Dermatol (2014); 71:e131-e132 PMID:25219728; http://dx.doi.org/10.1016/j.jaad.2014.03.045
203. Bernstein P, Furuya Y, Steinberg S, Scully B, Larussa P, Gershon AA. Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient. Am J Infect Control (2011); 39:247-9 PMID:21269735; http://dx.doi.org/10.1016/j.ajic.2010.06.027
204. Han SB, Hwang JM, Kim JS, Yang HK. Optic neuritis following Varicella zoster vaccination: report of two cases. Vaccine (2014); 32:4881-4 PMID:25045807; http://dx.doi.org/10.1016/j.vaccine.2014.07.023
205. Macartney K, Heywood A, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database Syst Rev (2014); 6:CD001833 PMID:24954057
206. Bhalla P, Forrest GN, Gershon M, Zhou Y, Chen J, LaRussa P, Steinberg S, Gershon AA. Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation. Clin Infect Dis (2015); 60:1068-74 PMID:25452596
207. Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberá J, et al., ZOE-50 Study Group. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med (2015); 372:2087-2096 PMID:25916341; http://dx.doi.org/10.1056/NEJMoa1501184
208. Vesikari T, Hardt R, Rümke HC, Icardi G, Montero J, Thomas S, Sadorge C, Fiquet A. Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years. Hum Vaccin Immunother (2013); 9:858-64 PMID:23319176; http://dx.doi.org/10.4161/hv.23412
209. Loulergue P, Moulin F, Vidal-Trecan G, Absi Z, Demontpion C, Menager C, Gorodetsky M, Gendrel D, Guillevin L, Launay O. Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations. Vaccine (2009); 27:4240-3 PMID:19481314; http://dx.doi.org/10.1016/j.vaccine.2009.03.039
210. Loulergue P, Launay O. Vaccinations among medical and nursing students: coverage and opportunities. Vaccine (2014); 32:4855-9 PMID:24503273; http://dx.doi.org/10.1016/j.vaccine.2014.01.014
211. Galanakis E, Jansen A, Lopalco PL, Giesecke J. Ethics of mandatory vaccination for healthcare workers. Euro Surveill (2013); 18:20627 PMID:24229791
212. Van den Hoven M, Verweij M. Professional solidarity: the case of influenza immunization. Am J Bioeth (2013); 13:51-2 PMID:23952837; http://dx.doi.org/10.1080/15265161.2013.813606
213. Zimmerman RK. Ethical analyses of institutional measures to increase health care worker influenza vaccination rates. Vaccine (2013); 31:6172-6 PMID:24188752; http://dx.doi.org/10.1016/j.vaccine.2013.10.066
214. Ulrich MR. Guidance from vaccination jurisprudence. Am J Bioeth (2013); 13:40-2 PMID:23952832; http://dx.doi.org/10.1080/15265161.2013.813608
215. Perry JE. Before the mandate: cultivating an organizational culture of trust and integrity. Am J Bioeth (2013); 13:42-4 PMID:23952833; http://dx.doi.org/10.1080/15265161.2013.813600
216. Omer SB. Applying Kass’s public health ethics framework to mandatory health care worker immunization: the devil is in the details. Am J Bioeth (2013); 13:55-7 PMID:23952839; http://dx.doi.org/10.1080/15265161.2013.825122
217. Schwartz JL. Evidence and ethics in mandatory vaccination policies. Am J Bioeth (2013); 13:46-8 PMID:23952835; http://dx.doi.org/10.1080/15265161.2013.815023
218. Zhou L, Su Q, Xu Z, Feng A, Jin H, Wang S, Feng Z. Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12). PLoS ONE (2013); 8: e73724 PMID:24040041; http://dx.doi.org/10.1371/journal.pone.0073724
219. European Centre for Disease Prevention and Control. Seasonal influenza vaccination in Europe-Overview of vaccination recommendations and coverage rates in the EU Member States for the 2012-13 influenza season. Stockholm: ECDC (2015)
220. Pulcini C, Massin S, Launay O, Verger P. Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: a 2010 survey. Vaccine (2013); 31:3943-9 PMID:23806242; http://dx.doi.org/10.1016/j.vaccine.2013.06.039
221. VENICE II Consortium. Seasonal influenza vaccination in EU/EEA, influenza season 2010_11. (2012)
222. Böhmer MM, Walter D, Müters S, Krause G, Wichmann O. Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: results from a national health update survey. Vaccine (2011); 29:4492-8 PMID:21545822; http://dx.doi.org/10.1016/j.vaccine.2011.04.039
223. Toska A, Saridi M, Wozniak G, Souliotis K, Korovesis K, Apostolopoulou E. Influenza vaccination among nurses in Greece. Am J Infect Control (2012); 40:276-8 PMID:21840087; http://dx.doi.org/10.1016/j.ajic.2011.04.050
224. Barbadoro P, Marigliano A, Di Tondo E, Chiatti C, Di Stanislao F, D’Errico MM, Prospero E. Determinants of influenza vaccination uptake among Italian healthcare workers. Hum Vaccin Immunother (2013); 9:911-6 PMID:24064543
225. La Torre G, Mannocci A, Ursillo P, Bontempi C, Firenze A, Panico MG, Sferrazza A, Ronga C, D’Anna A, Amodio E, et al. Prevalence of influenza vaccination among nurses and ancillary workers in Italy: systematic review and meta analysis. Hum Vaccin (2011); 7:728-33 PMID:21705859
226. VENICE II Consortium. Seasonal influenza vaccination in EU/EEA, influenza season 2011_12. (2013)
227. Rodríguez-Rieiro C, Hernández-Barrera V, Carrasco-Garrido P, de Andres AL, Jiménez-García R. Vaccination against 2008/2009 and 2009/2010 seasonal influenza in Spain: coverage among high risk subjects, HCWs, immigrants and time trends from the 2005/2006 campaign. Vaccine (2011); 29:6029-34; http://dx.doi.org/10.1016/j.vaccine.2011.06.030
228. Zhang J, While AE, Norman IJ. Seasonal influenza vaccination knowledge, risk perception, health beliefs and vaccination behaviours of nurses. Epidemiol Infect (2012); 140:1569-77 PMID:22093804; http://dx.doi.org/10.1017/S0950268811002214
229. Hothersall EJ, de Bellis-Ayres S, Jordan R. Factors associated with uptake of pandemic influenza vaccine among general practitioners and practice nurses in Shropshire, UK. Prim Care Respir J (2012); 21:302-7 PMID:22811218; http://dx.doi.org/10.4104/pcrj.2012.00056
230. Ishola DA, Permalloo N, Cordery RJ, Anderson SR. Midwives’ influenza vaccine uptake and their views on vaccination of pregnant women. J Public Health (Oxf) (2013); 35:570-7 PMID:23365262; http://dx.doi.org/10.1093/pubmed/fds109
231. Lu P, Ding H, Black CL. H1N1 and seasonal influenza vaccination of US healthcare personnel, 2010. Am J Prev Med (2012); 43:282-92 PMID:22898121; http://dx.doi.org/10.1016/j.amepre.2012.05.005
232. Lu PJ, Singleton JA, Euler GL, Williams WW, Bridges CB. Seasonal influenza vaccination coverage among adult populations in the United States, 2005-2011. Am J Epidemiol (2013); 178:1478-87 PMID:24008912; http://dx.doi.org/10.1093/aje/kwt158
233. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among health-care personnel-United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep (2011); 60:1073-7 PMID:21849963
234. Lee SJ, Harrison R, Rosenberg J, McLendon P, Boston E, Lindley MC. Influenza vaccination among health care personnel in California: 2010-2011 influenza season. Am J Infect Control (2013); 41:e65-e71 PMID:23394860; http://dx.doi.org/10.1016/j.ajic.2012.10.014
235. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among health-care personnel: 2011-12 influenza season, United States. MMWR Morb Mortal Wkly Rep. (2012); 61:753-7 PMID:23013720
236. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among health-care personnel-United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep (2013); 62:781-6 PMID:24067582
237. Black CL, Yue X, Ball SW, Donahue SM, Izrael D, de Perio MA, Laney AS, Lindley MC, Graitcer SB, Lu PJ, et al., Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among health care personnel-United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep (2014); 63:805-11 PMID:25233281
238. Lindley MC, Bridges CB, Strikas RA, Kalayil EJ, Woods LO, Pollock D, Sievert D; Centers for Disease Control and Prevention (CDC)., Centers for Disease Control and Prevention (CDC). Influenza vaccination performance measurement among acute care hospital-based health care personnel-United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep (2014); 63:812-5 PMID:25233282